HRUSKA-PLOCHAN, Marian, Vera I WIERSMA, Katharina M BETZ, Izaskun MALLONA, Silvia RONCHI, Zuzanna MANIECKA, Eva-Maria HOCK, Elena TANTARDINI, Florent LAFERRIERE, Sonu SAHADEVAN, Vanessa HOOP, Igor DELVENDAHL, Manuela PEREZ-BERLANGA, Beatrice GATTA, Martina PANATTA, van der Bourg ALEXANDER, Dáša BOHAČIAKOVÁ, Puneet SHARMA, De Vos LAURA, Karl FRONTZEK, Adriano AGUZZI, Tammaryn LASHLEY, Mark D ROBINSON, Theofanis KARAYANNIS, Martin MUELLER, Andreas HIERLEMANN and Magdalini POLYMENIDOU. A model of human neural networks reveals NPTX2 pathology in ALS and FTLD. Nature. BERLIN: NATURE PORTFOLIO, 2024, vol. 626, No 8001, p. 1-45. ISSN 0028-0836. Available from: https://dx.doi.org/10.1038/s41586-024-07042-7.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name A model of human neural networks reveals NPTX2 pathology in ALS and FTLD
Authors HRUSKA-PLOCHAN, Marian, Vera I WIERSMA, Katharina M BETZ, Izaskun MALLONA, Silvia RONCHI, Zuzanna MANIECKA, Eva-Maria HOCK, Elena TANTARDINI, Florent LAFERRIERE, Sonu SAHADEVAN, Vanessa HOOP, Igor DELVENDAHL, Manuela PEREZ-BERLANGA, Beatrice GATTA, Martina PANATTA, van der Bourg ALEXANDER, Dáša BOHAČIAKOVÁ (703 Slovakia, belonging to the institution), Puneet SHARMA, De Vos LAURA, Karl FRONTZEK, Adriano AGUZZI, Tammaryn LASHLEY, Mark D ROBINSON, Theofanis KARAYANNIS, Martin MUELLER, Andreas HIERLEMANN and Magdalini POLYMENIDOU.
Edition Nature, BERLIN, NATURE PORTFOLIO, 2024, 0028-0836.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10601 Cell biology
Country of publisher Germany
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 64.800 in 2022
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1038/s41586-024-07042-7
UT WoS 001183983000018
Keywords in English human neural networks; model; ALS; FTLD; NPTX2 pathology
Tags 14110517, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 10/6/2024 14:23.
Abstract
Human cellular models of neurodegeneration require reproducibility and longevity, which is necessary for simulating age-dependent diseases. Such systems are particularly needed for TDP-43 proteinopathies1, which involve human-specific mechanisms2-5 that cannot be directly studied in animal models. Here, to explore the emergence and consequences of TDP-43 pathologies, we generated induced pluripotent stem cell-derived, colony morphology neural stem cells (iCoMoNSCs) via manual selection of neural precursors6. Single-cell transcriptomics and comparison to independent neural stem cells7 showed that iCoMoNSCs are uniquely homogenous and self-renewing. Differentiated iCoMoNSCs formed a self-organized multicellular system consisting of synaptically connected and electrophysiologically active neurons, which matured into long-lived functional networks (which we designate iNets). Neuronal and glial maturation in iNets was similar to that of cortical organoids8. Overexpression of wild-type TDP-43 in a minority of neurons within iNets led to progressive fragmentation and aggregation of the protein, resulting in a partial loss of function and neurotoxicity. Single-cell transcriptomics revealed a novel set of misregulated RNA targets in TDP-43-overexpressing neurons and in patients with TDP-43 proteinopathies exhibiting a loss of nuclear TDP-43. The strongest misregulated target encoded the synaptic protein NPTX2, the levels of which are controlled by TDP-43 binding on its 3 ' untranslated region. When NPTX2 was overexpressed in iNets, it exhibited neurotoxicity, whereas correcting NPTX2 misregulation partially rescued neurons from TDP-43-induced neurodegeneration. Notably, NPTX2 was consistently misaccumulated in neurons from patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration with TDP-43 pathology. Our work directly links TDP-43 misregulation and NPTX2 accumulation, thereby revealing a TDP-43-dependent pathway of neurotoxicity.
Links
GJ18-25429Y, research and development projectName: Funkční studie mikroRNA u nerálních kmenových buněk v průběhu diferenciace
Investor: Czech Science Foundation
PrintDisplayed: 6/7/2024 20:59